One-Hour Glucose on OGTT at Three Months Postpartum Predicts Dysglycemia
By Elana Gotkine HealthDay Reporter
TUESDAY, March 4, 2025 -- Higher one-hour blood glucose on an oral glucose tolerance test (OGTT) at three months postpartum can predict the risk for dysglycemia at five years, according to a study published online March 3 in Diabetes Care.
Ravi Retnakaran, M.D., from Mount Sinai Hospital in Toronto, and colleagues compared one-hour and two-hour OGTT measurements at three months postpartum as predictors of dysglycemia during the first five years postpartum. Three hundred sixty-nine women across a range of glucose tolerance in pregnancy underwent multisample two-hour 75-g OGTTs at multiple points postpartum (three months, one year, three years, and five years).
The researchers found that at the three-month OGTT, one-hour glucose identified 60 of 70 women concurrently diagnosed with dysglycemia by two-hour glucose and diagnosed an additional 96 women. There was a progressive increase in the cumulative incidence of dysglycemia over five years by tertile of one-hour glucose on the three-month OGTT. One-hour glucose was the strongest predictor of dysglycemia on regression analyses (change in concordance index [CCI], 16.1 percent), followed by two-hour glucose (change in CCI,14.9 percent). One-hour glucose emerged as the strongest predictor of dysglycemia among women with gestational diabetes mellitus, followed by two-hour glucose (changes in CCI, 13.0 and 12.8 percent, respectively).
"The findings reported herein support consideration of a one-hour OGTT as a potential solution to increase the uptake of postpartum reclassification following hyperglycemia in pregnancy and thereby address a missed opportunity in current clinical practice," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
FRIDAY, July 25, 2025 -- Antiobesity medications (AOMs) yield weight loss during use, followed by weight regain after discontinuation of treatment, according to a review published...
Patients Face High Out-of-Pocket Costs After Incident Cancer Diagnosis
FRIDAY, July 25, 2025 -- Patients face high out-of-pocket costs (OOPCs) after an incident diagnosis of cancer, with costs increasing with stage of diagnosis, according to a study...
Exposure to PFAS Mixtures Linked to Increased Odds of Type 2 Diabetes
FRIDAY, July 25, 2025 -- In multiethnic populations, exposure to per- and polyfluoroalkyl substance (PFAS) mixtures may be associated with increased odds of type 2 diabetes (T2D)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.